Journal of the International AIDS Society

Papers
(The H4-Index of Journal of the International AIDS Society is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Understanding adaptive responses in PrEP service delivery in Belgian HIV clinics: a multiple case study using an implementation science framework130
HIV Glasgow, 23–26 October 2022, Glasgow, UK / Virtual74
Systematic review and meta‐analysis of retention and disengagement after initiation on antiretroviral therapy in low‐ and middle‐income countries after the introduction of Universal Test and Treat pol67
Effects of Stop‐Work orders on HIV testing, treatment and programmes for prevention of vertical transmission in four sub‐Saharan African countries65
Population‐level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART)60
Counselling behavioural interventions for HIV, STI and viral hepatitis among key populations: a systematic review of effectiveness, values and preferences, and cost studies52
When and how to intervene to improve the health of children born HIV‐free49
Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource‐limit45
Do not forget the children: a model‐based analysis on the potential impact of COVID‐19‐associated interruptions in paediatric HIV prevention and care43
Sustaining the HIV/AIDS response: PEPFAR's vision41
“If they had a place to live, they would be taking medication”: a qualitative study identifying strategies for engaging street‐connected young people in the HIV prevention‐care continuum in Ken39
Adherence challenges with daily oral pre‐exposure prophylaxis during pregnancy and the postpartum period in South African women: a cohort study39
Effectiveness and safety of tenofovir alafenamide in children and adolescents living with HIV: a systematic review37
36
Exploring potential drug−drug interactions between masculinizing hormone therapy and oral pre‐exposure prophylaxis (F/TDF and F/TAF) among transgender men (iMACT study): a randomized, open‐label pharm36
35
A cross‐sectional assessment of injection of “salts” and HIV transmission‐related behaviours among a cohort of people who inject drugs in Kyrgyzstan34
Community‐led monitoring: a voice for key populations in Zimbabwe34
Issue Information33
Effectiveness of HIV self‐testing when offered within assisted partner services in Western Kenya (APS‐HIVST Study): a cluster randomized controlled trial33
Using community conversations to integrate violence screening and referrals into HIV care for young women living with HIV in Lusaka, Zambia32
Differentiating the incidence and burden of HIV by age among women who sell sex: a systematic review and meta‐analysis32
Breaking down relationship barriers to increase PrEP uptake and adherence among adolescent girls and young women in Kenya: safety and preliminary effectiveness results from a pilot cluster‐randomized 32
Issue Information32
Ageing with HIV: a longitudinal study of markers of resilience in young adults with perinatal exposure to HIV, with or without perinatally acquired HIV32
Patterns of daily oral HIV PrEP adherence among people who inject drugs in Ukraine: an analysis of biomarkers31
Contents31
A cross‐sectional study evaluating the frequency of HIV drug resistance mutations among individuals diagnosed with HIV‐1 in tenofovir disoproxil fumarate‐based pre‐exposure prophylaxis rollout program30
The lavender purge29
Issue Information29
0.093470096588135